Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 65 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8716473

    Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase

    SENTINEL ONCOLOGY LIMITED · Granted May 6, 2014 · Expires May 1, 2034

    granted

  2. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted

  3. US 8710032

    Inhibitors of the mevalonate pathway of Streptococcus pneumoniae

    Northwestern University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  4. US 8710081

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  5. US 8710223

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  6. US 8703938

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  7. US 8697709

    Fused ring heteroaryl kinase inhibitors

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  8. US 8697628

    Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  9. US 8697699

    Imidazopyrazine SYK inhibitors

    GILEAD CONNECTICUT, INC. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  10. US 8697704

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  11. US 8697698

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  12. US 8691848

    Inhibitors of caspases

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  13. US 8691868

    Neprilysin inhibitors

    Theravance, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  14. US 8691831

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  15. US 8691852

    Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

    Amirall, S.A. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  16. US 8691828

    Thienopyrimidine as CDC7 kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  17. US 8691501

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  18. US 8691184

    Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  19. US 8691758

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  20. US 8686184

    Neprilysin inhibitors

    Theravance, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  21. US 8685926

    Compositions and method for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  22. US 8686010

    Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  23. US 8686143

    Compounds useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  24. US 8680046

    Inhibitors of viral integrase and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.